Actualités et communiqués de presse Conformis 2026 | CFMS | ISIN US20717E1010

Actualités Eulerpool Conformis

Actualités de l'action Conformis

Conformis est suivi par de nombreux journalistes et investisseurs dans le monde. Nous rassemblons ici les dernières actualités concernant Conformis.

11 mars·
Yahoo
Gary Fischetti nominated to join Conformis’ Board of Directors
2 mars·
Yahoo
Conformis Suspends All Distribution Operations and Business Development in Russia
28 février·
CNBC
Disney, Warner Bros, other Hollywood studios pause theatrical releases in Russia
28 février·
Yahoo
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
24 février·
CNBC
Disney+ and HBO Max show streaming strength against Netflix
27 janvier·
CNBC
Stocks making the biggest moves premarket: McDonald's, Blackstone, Netflix and others
27 janvier·
CNBC
Comcast reports better-than-expected Q4 earnings, raises dividend
24 janvier·
CNBC
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
24 janvier·
CNBC
What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020
24 janvier·
CNBC
Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more
23 janvier·
CNBC
Earnings playbook: A complete guide to this week's reports, including the first of tech
20 janvier·
CNBC
Netflix quietly admits streaming competition is eating into growth
11 janvier·
CNBC
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda

Communiqués de presse relatifs à l'action Conformis

Conformis publie régulièrement sur son site web des communiqués pertinents pour les investisseurs.

8 août•
Conformis
Conformis Reports Second Quarter 2022 Financial Results
1 août•
Conformis
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
28 juillet•
Conformis
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
5 juillet•
Conformis
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
24 mai•
Conformis
Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity
10 mai•
Conformis
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference
4 mai•
Conformis
Conformis Reports First Quarter 2022 Financial Results
11 avril•
Conformis
Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022
1 avril•
Conformis
Conformis, Inc. Appoints Michael Fillion as Chief Operating Officer
22 mars•
Conformis
Conformis Partners with Synchrony to Offer CareCredit Financial Services to Orthopedic Patients
14 mars•
Conformis
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
11 mars•
Conformis
Gary Fischetti nominated to join Conformis’ Board of Directors
2 mars•
Conformis
Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results
2 mars•
Conformis
Conformis Suspends All Distribution Operations and Business Development in Russia
28 février•
Conformis
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
24 février•
Conformis
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel
18 février•
Conformis
Conformis, Inc. to Participate in Upcoming Investor Conferences
20 janvier•
Conformis
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
6 janvier•
Conformis
Conformis, Inc. Provides Business Update and Initial Expectations for 2022
4 janvier•
Conformis
Conformis, Inc. to Provide Business Update and Initial Expectations for 2022 on January 6, 2022
23 décembre•
Conformis
Conformis, Inc. Announces Departure of Chief Legal Officer, Corporate Secretary
8 novembre•
Conformis
Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported
3 novembre•
Conformis
Conformis Reports Third Quarter 2021 Financial Results
4 octobre•
Conformis
Conformis, Inc. to Release Third Quarter 2021 Financial Results on November 3, 2021
29 septembre•
Conformis
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
20 septembre•
Conformis
Conformis, Inc. Provides Business Update
7 septembre•
Conformis
Conformis, Inc. to Participate in Upcoming Investor Conferences
18 août•
Conformis
Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System
4 août•
Conformis
Conformis Reports Second Quarter 2021 Financial Results
14 juillet•
Conformis
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference

Conformis News 2026

Cette page contient toutes les actualités actuelles, analyses et communiqués de presse pour l'action Conformis (CFMS, ISIN : US20717E1010). Cela inclut les actualités Eulerpool, les analyses d'entreprise et les communiqués de presse officiels. Les données sont mises à jour régulièrement pour fournir aux investisseurs un aperçu complet des derniers développements chez Conformis.

Conformis Action

Conformis Conformis Inc is a medical technology company specializing in the development, manufacturing, and marketing of custom implantable joint prostheses. The company is based in the United States and has its headquarters in Billerica, Massachusetts.